2-es típusú cukorbetegség: vizsgálatok itt: Dél-Korea
66 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in Dél-KoreaCGM-Based Glycemic Analysis After ESI
- Where
- Seoul
- Életkor
- 20 év to 60 év
- People
- 36
- Run by
- Korea University Anam Hospital
See details and how to joinNCT07280780 - No phaseTaking peopleSurgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
- Where
- Seoul
- Életkor
- 20 év to 69 év
- People
- 120
- Run by
- Korea University Anam Hospital
See details and how to joinNCT04284943 - 3. fázisNot yet taking people in Dél-KoreaA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Where
- Bucheon-si, Gyeonggi-do, Jongno-gu, Junggu, Seoul
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00 - 4. fázisTaking peopleCilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
- Where
- Seongnam-si
- Életkor
- 19 év and over
- People
- 1200
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT07719894 - No phaseCsak meghívásosPrevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 800 000
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07673822 - 3. fázisNot yet taking people in Dél-KoreaTo Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
- Where
- Seoul
- Életkor
- 18 év to 80 év
- People
- 510
- Run by
- Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT07619833 - 3. fázisTaking peopleA Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
- Where
- Gyeonggi-do
- Életkor
- 19 év and over
- People
- 118
- Run by
- Hanmi Pharmaceutical Company Limited
See details and how to joinNCT07379333 - 4. fázisTaking peopleCholine Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
- Where
- Seongnam-si
- Életkor
- 20 év and over
- People
- 56
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT05365425 - 4. fázisTaking peopleAtmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
- Where
- Seongnam-si
- Életkor
- 20 év to 80 év
- People
- 105
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT05365438 - No phaseCsak meghívásosRegulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Where
- Jeonlabuk-do
- Életkor
- 19 év and over
- People
- 600
- Run by
- Novo Nordisk A/S
See details and how to joinNCT05689372 - 4. fázisTaking peopleEnavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
- Where
- Seongnam-si
- Életkor
- 20 év to 80 év
- People
- 120
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT06399835 - 4. fázisTaking peopleClopidogrel Versus Cilostazol on Vessels
- Where
- Seongnam-si
- Életkor
- 19 év and over
- People
- 120
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT06402747 - 3. fázisTaking peopleClinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 228
- Run by
- Hanlim Pharm. Co., Ltd.
See details and how to joinNCT07552389 - 2. fázisFut, nem toborozA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Busan, Goyang-si, Gyeonggi-do, Seoul
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseTaking peopleModerate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
- Where
- Seoul
- Életkor
- 70 év and over
- People
- 2186
- Run by
- Sin Gon Kim
See details and how to joinNCT07359105 - 4. fázisTaking peopleGlycemic Variability of Combination Therapies in T2DM
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 178
- Run by
- JW Pharmaceutical
See details and how to joinNCT07442006 - 4. fázisNot yet taking people in Dél-KoreaEvaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 200
- Run by
- Chong Kun Dang Pharmaceutical
See details and how to joinNCT07365358 - 3. fázisTaking peopleEvaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
- Where
- Anyang, Buchon, Busan, Cheonan, Daegu, Daejeon, Goyang-si, Guri-si, Gwangju, Iksan, Inchon, Jeonju, Seongnam, Seoul, Suwon, Wŏnju, Yongin-si
- Életkor
- 19 év to 80 év
- People
- 240
- Run by
- CMG Pharmaceutical Co. Ltd
See details and how to joinNCT06772168 - No phaseTaking peopleContinuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use
- Where
- Seoul
- Életkor
- 19 év to 80 év
- People
- 150
- Run by
- Kangbuk Samsung Hospital
See details and how to joinNCT07336329 - 2. fázisNot yet taking people in Dél-KoreaClinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 288
- Run by
- Dong-A ST Co., Ltd.
See details and how to joinNCT07239440 - No phaseTaking peopleA Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
- Where
- Incheon
- Életkor
- 19 év and over
- People
- 9000
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT05970237 - 4. fázisTaking peopleA Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 204
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06972732 - 4. fázisTaking peopleEffects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
- Where
- Seoul
- Életkor
- 20 év to 79 év
- People
- 30
- Run by
- Korea University Anam Hospital
See details and how to joinNCT06782139 - 3. fázisTaking peopleEfficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 171
- Run by
- Celltrion
See details and how to joinNCT07093476 - 4. fázisNot yet taking people in Dél-KoreaEffect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors
- Where
- Seoul
- Életkor
- 19 év to 75 év
- People
- 100
- Run by
- Yonsei University
See details and how to joinNCT07108985